Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 31 August 2022
Accepted: 30 December 2022
First Online: 17 January 2023
Declarations
:
: C Hu, M Vetter, and D Ouellet are employees of Janssen Research & Development, LLC and own stock/stock options. A Vermeulen is an employee of Janssen Research & Development, a division of Janssen Pharmaceutica NV and owns stock/stock options.